Mogamulizumab (Anti-CCR4) in HTLV-1-Associated Myelopathy.
Sato T, Coler-Reilly ALG, Yagishita N, Araya N, Inoue E, Furuta R, Watanabe T, Uchimaru K, Matsuoka M, Matsumoto N, Hasegawa Y, Yamano Y.
Sato T, et al. Among authors: yamano y.
N Engl J Med. 2018 Feb 8;378(6):529-538. doi: 10.1056/NEJMoa1704827.
N Engl J Med. 2018.
PMID: 29414279
Free article.
Clinical Trial.